Sequential Secures $3.5M Funding in First Equity Round for Skin Health Innovation

Sequential, a leader in genomic testing, closes its first equity round with $3.5 million funding. The company plans to use the funding to develop an AI-powered discovery engine for active complexes and bioactive ingredients.